Skip to content
Forge Biologics
  • About
    • About
    • Mission & Approach
    • Leadership
    • Board
  • Services
    • Manufacturing Services
    • Technology
  • Science
    • Science
    • Pipeline
    • About Gene Therapy
    • FBX-101 for Krabbe Disease
  • Careers
  • News & Insights
    • News
    • Events
    • Insights
    • Media Kit
  • Connect

Marina Corleto

Profile picture of Marina Corleto

Posts by Marina Corleto

Columbus grows its gene therapy expertise

Posted on May 12, 2022 (May 12, 2022)

[…]

Read More… from Columbus grows its gene therapy expertise

Posted in Biologics News, In the news

Forge Biologics shares plans for growth at Meeting on the Med

Posted on April 29, 2022 (May 2, 2022)

[…]

Read More… from Forge Biologics shares plans for growth at Meeting on the Med

Posted in Biologics News, In the news

Forge Biologics closed an additional $80M financing to accelerate the company’s planned CDMO expansion

Posted on January 13, 2022 (January 18, 2022)

[…]

Read More… from Forge Biologics closed an additional $80M financing to accelerate the company’s planned CDMO expansion

Posted in Biologics News, In the news

Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord

Posted on October 6, 2021 (October 15, 2021)

[…]

Read More… from Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord

Posted in Biologics News, In the newsTagged biotechnology, CDMO, Forge Biologics, Gene Therapy, Krabbe Disease

Solid Biosciences, Forge Biologics Enter Development and Manufacturing Pact

Posted on October 5, 2021 (October 14, 2021)

[…]

Read More… from Solid Biosciences, Forge Biologics Enter Development and Manufacturing Pact

Posted in Biologics News, In the newsTagged biotechnology, CDMO, cGMP, Forge Biologics, Gene Therapy

EMA Orphan Drug Designation for Forge Biologics’ gene therapy for Krabbe disease

Posted on September 23, 2021 (October 14, 2021)

[…]

Read More… from EMA Orphan Drug Designation for Forge Biologics’ gene therapy for Krabbe disease

Posted in Biologics News, In the newsTagged biotechnology, CDMO, Forge Biologics, Gene Therapy, Krabbe Disease

Forge Biologics to Present at Jefferies Virtual Healthcare Conference

Posted on June 1, 2021 (June 15, 2021)

COLUMBUS, OHIO June 1, 2021—Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that its CEO, President […]

Read More… from Forge Biologics to Present at Jefferies Virtual Healthcare Conference

Posted in Biologics News, Press ReleasesTagged conferences, Jefferies Virtual Healthcare

Forge Biologics to Present at the ASGCT’s Annual Meeting

Posted on May 12, 2021 (July 13, 2021)

COLUMBUS, OHIO May 10, 2021 – Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that David […]

Read More… from Forge Biologics to Present at the ASGCT’s Annual Meeting

Posted in Biologics News, Press ReleasesTagged ASGT, cellular therapies, conferences, genetic therapies, pEMBR
Copyright Forge Biologics - All Rights Reserved Cookie Notice | Privacy Policy

I agree to the Cookie Notice and Privacy Policy

I agree